Frost & Sullivan awards Chr. Hansen for its pioneering work in probiotics.
Based on a thorough and unbiased screening of the European probiotics industry, global research and consultancy company Frost & Sullivan awards Chr. Hansen the “2012 European Product Leadership Award in Probiotics”.
According to Frost & Sullivan, “Chr. Hansen is a pioneer in the field of probiotics and has launched an exclusive product line - Probio-Tec®, a unique set of probiotic products that are intended not only to address every condition associated with digestive health but also improves and maintains the immune health. It caters to almost every group of the population – infants, elderly and the general population. The Probio-Tec® range is a perfect combination of innovation, technology and science.”
The substantiation continues: “Chr. Hansen’s strains are well documented and are a result of extensive R&D initiatives and substantiate the product’s safety, purity and quality. Chr. Hansen has put together its 138 years of hard earned experience in creating a product line that delivers quality and performance in every aspect.”
Superior probiotic offering
“We are very proud to receive this important accolade,” comments Chr. Hansen’s Lasse Nagell, Vice President, Sales & Marketing, Human Health & Nutrition. “Our customers will be pleased to learn that an in-depth, third-party screening of the highly competitive European probiotics market concludes that Chr. Hansen's probiotic offering is superior. The award is a prestigious recognition of our accomplishments in the probiotics industry.”
Backed by extensive analysis
The Product Leadership Award is backed by extensive analysis; companies identified, and product features, innovation, acceptance, value and quality are monitored and evaluated through primary analyst research. This stringent methodology positions Chr. Hansen as a superior market participant.
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. The products include cultures, enzymes, probiotics and natural colors, and all solutions are based on strong research and development competencies coupled with significant technology investments. Revenue in the 2013/14 financial year was EUR 756 million. The company holds a leading market position in all its divisions: Cultures & Enzymes, Health & Nutrition and Natural Colors. It has more than 2,500 dedicated employees in over 30 countries and main production facilities in Denmark, France, USA and Germany. Chr. Hansen was founded in 1874 and is listed on NASDAQ OMX Copenhagen.